🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
The study is conducted in order to find out if repeated doses of the monocl...
Status
Completed
Location
Study Site
Start Date
2010-12
Trial ID
NCT01481493
This study will evaluate the efficacy, safety and patient reported outcomes...
Status
Unknown
Location
Multiple Locations
Start Date
2020-09-01
Trial ID
NCT04516655
Treatments Being Tested
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This study will assess the efficacy and safety of different treatment regim...
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00074438
Treatments Being Tested
This prospective, within subject clinical trial aims to evaluate the effica...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-01
Trial ID
NCT06877455
Treatments Being Tested
The goal of the present study is to evaluate if addition of methotrexate ca...
Status
Completed
Location
The E. Wolfson.Medical Center
Start Date
2015-07
Trial ID
NCT02269358
Treatments Being Tested
Objectives: A. Primary objective: 1 To assess the feasibility and the eff...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-09-12
Trial ID
NCT00866749
This study is a multicenter, randomized, double-blinded, controlled trial w...
Status
Unknown
Location
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Start Date
2019-11-25
Trial ID
NCT04136262
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as fludarabine and melpha...
Status
Terminated
Location
Cardinal Bernardin Cancer Center at Loyola University Medical Center
Start Date
2005-07
Trial ID
NCT00121186